Skip to main content
Top
Published in: Clinical Rheumatology 3/2010

01-03-2010 | Original Article

The prognostic factors of systemic sclerosis for survival among Koreans

Authors: Jinhyun Kim, Sue Kyung Park, Ki Won Moon, Eun Young Lee, Yun Jong Lee, Yeong Wook Song, Eun Bong Lee

Published in: Clinical Rheumatology | Issue 3/2010

Login to get access

Abstract

Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by fibrosis of the skin and internal organs, which can cause significant morbidity and mortality. The prognostic factors for survival were not fully evaluated in Asian population. We investigated the prognostic factors for survival of SSc among Korean patients. A total of 243 SSc patients were enrolled from Seoul National University Hospital between 1972 and 2007. Age at onset, gender, cutaneous subset, autoantibody status, major organ involvement, and occurrence of malignancy were evaluated with all-cause mortality as the end point. A multivariate Cox proportional hazard model was used to retrieve the prognostic factors for survival. During the follow-up of 1,967 person-years, 33 patients died. Old age at onset (hazard ratio [HR] 7.4, 95% confidence interval [95% CI] 1.9–28.1), diffuse cutaneous subset (HR 2.5, 95% CI 1.1–5.9), presence of anti-Scl-70 antibody (HR 3.0, 95% CI 1.2–7.1), forced vital capacity less than 70% (HR 2.8, 95% CI 1.3–6.2), and heart involvement (HR 4.2, 95% CI 1.7–10.2) were found to be significant risk factors for mortality in multivariate analysis. In Korean SSc patients, old age, diffuse cutaneous involvement, anti-Scl-70 antibody, and internal organ involvement are risk factors for mortality.
Literature
1.
go back to reference Agarwal SK, Tan FK, Arnett FC (2008) Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 34:17–40CrossRefPubMed Agarwal SK, Tan FK, Arnett FC (2008) Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 34:17–40CrossRefPubMed
2.
go back to reference Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37:223–235CrossRefPubMed Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37:223–235CrossRefPubMed
3.
go back to reference Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large us population. Arthritis Rheum 48:2246–2255CrossRefPubMed Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large us population. Arthritis Rheum 48:2246–2255CrossRefPubMed
4.
go back to reference Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 66:940–944CrossRefPubMed Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 66:940–944CrossRefPubMed
5.
go back to reference Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M et al (2003) Mortality and prognostic factors in spanish patients with systemic sclerosis. Rheumatol (Oxford) 42:71–75CrossRef Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M et al (2003) Mortality and prognostic factors in spanish patients with systemic sclerosis. Rheumatol (Oxford) 42:71–75CrossRef
6.
go back to reference Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 81:139–153CrossRefPubMed Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 81:139–153CrossRefPubMed
8.
go back to reference Czirjak L, Kumanovics G, Varju C, Nagy Z, Pakozdi A, Szekanecz Z et al (2008) Survival and causes of death in 366 hungarian patients with systemic sclerosis. Ann Rheum Dis 67:59–63CrossRefPubMed Czirjak L, Kumanovics G, Varju C, Nagy Z, Pakozdi A, Szekanecz Z et al (2008) Survival and causes of death in 366 hungarian patients with systemic sclerosis. Ann Rheum Dis 67:59–63CrossRefPubMed
9.
go back to reference Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ et al (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118:2–10CrossRefPubMed Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ et al (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118:2–10CrossRefPubMed
10.
go back to reference Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454–2459PubMed Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454–2459PubMed
11.
go back to reference Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J et al (2009) Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French itinerair-sclerodermie study. Rheumatol (Oxford) 48:304–308CrossRef Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J et al (2009) Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French itinerair-sclerodermie study. Rheumatol (Oxford) 48:304–308CrossRef
12.
go back to reference Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755CrossRefPubMed Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755CrossRefPubMed
13.
go back to reference Simeon CP, Armadans L, Fonollosa V, Vilardell M, Candell J, Tolosa C et al (1997) Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis 56:723–728CrossRefPubMed Simeon CP, Armadans L, Fonollosa V, Vilardell M, Candell J, Tolosa C et al (1997) Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis 56:723–728CrossRefPubMed
14.
go back to reference Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444CrossRefPubMed Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444CrossRefPubMed
15.
go back to reference Nishioka K, Katayama I, Kondo H, Shinkai H, Ueki H, Tamaki K et al (1996) Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol 23:677–682PubMed Nishioka K, Katayama I, Kondo H, Shinkai H, Ueki H, Tamaki K et al (1996) Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol 23:677–682PubMed
16.
go back to reference Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002) Causes of death and poor survival prognostic factors in Thai patients with systemic sclerosis. J Med Assoc Thai 85:1204–1209PubMed Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002) Causes of death and poor survival prognostic factors in Thai patients with systemic sclerosis. J Med Assoc Thai 85:1204–1209PubMed
17.
go back to reference Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
18.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
19.
go back to reference Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177:1248–1254CrossRefPubMed Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177:1248–1254CrossRefPubMed
20.
go back to reference Peters-Golden M, Wise RA, Schneider P, Hochberg M, Stevens MB, Wigley F (1984) Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine 63:221–231CrossRefPubMed Peters-Golden M, Wise RA, Schneider P, Hochberg M, Stevens MB, Wigley F (1984) Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine 63:221–231CrossRefPubMed
21.
go back to reference Tashkin DP, Clements PJ, Wright RS, Gong H Jr, Simmons MS, Lachenbruch PA et al (1994) Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis. Chest 105:489–495CrossRefPubMed Tashkin DP, Clements PJ, Wright RS, Gong H Jr, Simmons MS, Lachenbruch PA et al (1994) Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis. Chest 105:489–495CrossRefPubMed
22.
go back to reference Park SK, Kim TH, Jun JB, Jung SS, Bae SC, Kim TY et al (2001) The clinical features and autoantibody profile of progressive systemic sclerosis in Korea. J Korean Rheum Assoc 8:243–252 Park SK, Kim TH, Jun JB, Jung SS, Bae SC, Kim TY et al (2001) The clinical features and autoantibody profile of progressive systemic sclerosis in Korea. J Korean Rheum Assoc 8:243–252
23.
go back to reference Lee EB, Han CW, Baek HJ, Kang SW, Cha HS, Kim HA et al (1999) Study on the clinical characteristics of systemic sclerosis. Korean J Med 57:1053–1061 Lee EB, Han CW, Baek HJ, Kang SW, Cha HS, Kim HA et al (1999) Study on the clinical characteristics of systemic sclerosis. Korean J Med 57:1053–1061
24.
go back to reference Lee EB, Kim JY, Lee YJ, Abdallah A, Lympany P, Song YW (2004) Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis. Tissue antigens 63:491–495CrossRefPubMed Lee EB, Kim JY, Lee YJ, Abdallah A, Lympany P, Song YW (2004) Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis. Tissue antigens 63:491–495CrossRefPubMed
25.
go back to reference LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
26.
go back to reference Cepeda EJ, Reveille JD (2004) Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 16:723–732CrossRefPubMed Cepeda EJ, Reveille JD (2004) Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 16:723–732CrossRefPubMed
Metadata
Title
The prognostic factors of systemic sclerosis for survival among Koreans
Authors
Jinhyun Kim
Sue Kyung Park
Ki Won Moon
Eun Young Lee
Yun Jong Lee
Yeong Wook Song
Eun Bong Lee
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1324-7

Other articles of this Issue 3/2010

Clinical Rheumatology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.